Keywords: Seeding trials, Promotion, Epilepsy, Neurontin, Pfizer

Clinical study of epilepsy drug may have served primarily to promote drug and increase prescribing

Article | 28 June 2011

Print This

A review of documentation relating to a clinical trial of the epilepsy drug gabapentin (drug giant Pfizer’s Neurontin) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in